CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Corp. SVP of Quality Assurance acquired 6,688 shares (grant or award)
- 4 Shares withheld for taxes Corp. Exec. VP of Operations gave up 1,758 shares (to pay taxes)
- 4 Grant or award CFO, SVP & Treasurer acquired 19,397 shares (grant or award)
- 4 Shares withheld for taxes President gave up 7,523 shares (to pay taxes)
- 4 Grant or award CEO & Chief Science Officer acquired 178,929 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- CT ORDER Other Confidential Order
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 6,000 shares at $10.84 ($65,022)
- 4 Open-market buy Director bought 3,500 shares at $10.00 ($35,000)
- 4 Open-market buy Director bought 4,000 shares at an average $10.02 ($40,078)
- 4 Open-market buy Director bought 4,900 shares at $10.08 ($49,392)
Page 45 of 48 · 958 filings